Cincinnati Children’s Hospital Medical Center

Category

Cincinnati Children’s Hospital Conducting Phase I/II Clinical Trial Investigating BNT 162 COVID-19 Vaccine

Representing one of four sites across the United States, principal investigator and former Naval Officer Dr. Robert Frenck at Cincinnati Children’s Hospital is leading the Phase I/2 trials investigating the BNT 162 COVID-19 vaccine. Developed by a German biotech...

Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s researchers initially developed a transgenic mouse to model HLH (hemophagocytic lymphohistiocytosis), a deadly childhood immune disease but as it now turns out this effort may end up saving lives during the COVID-19 pandemic. Cincinnati...

Study at Cincinnati Children’s Hospital Medical Center Opens New Avenues for More Effective Autoimmune Therapies

Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases. In a study published online Dec. 17, 2019, researchers at Cincinnati...

Pin It on Pinterest